Administration’s Rule Requiring Drug Prices Be Shown In TV Ads Does Not Get Warm Welcome At Appeals Court

The judges seemed skeptical of the Trump administration's arguments that Congress implicitly gave HHS authority to require list price disclosure to ensure the "efficient administration" of Medicaid and Medicare. In other pharmaceutical news: drugmakers are testing new ways to pay for pricey treatments, the high cost of medicine is making patients forgo care, and more.

from Kaiser Health News https://ift.tt/2TmZHmk